# GO_biological_process_0066

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **B** — antibiotic biosynthetic process

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MELNGIRRRLATAKEAERHRLLLELIRAAAAEALDRPGPLPLDPGRAFGAQGVRGRAAGRLRERLSEATGLPLPATVVFDYPTPGALAGRLCALLLDEPAGPGGANGQMEAEEPIAIVGMGCRLPGDVRSPEGLWRLVHNGTDAISEFPEDRGWTVQQHPDPDHLGTTVTRHAGFLYDAPDFDAGFFAISPGEAVTIDPQHRLLLETTWKAVEDARIDPTSLRGSRTGVFVGLMYSEYGARIRRVPPGAEGYRVVGSMPSVASGRLAYTFGFEGPAVTVDTACSSSLVAMHLAAQSLRKGECTLAVAGGATVMATPWGYIEFSRQRGLAPDGRCRSFSADAAGSSWSEGVGVLLLERLSDARRHGHRVLAVVRGSAVNQDGASNGLTAPNGPAQQRVIRQALAHAGLTTAEVDAVDAHGAGTRLGDPIEAQALLATYGQGRPAGRPLWLGSLKSNIGHTQAAAGAAGVIKMVMAMRHGVLPRSLHITEPTPHVDWTSGAVELLTEARDWPADGRPRRAAVSSFGVGGTNAHIILEQAAPEPERPHAPEADGEPRPLPWPVSGHGAAGLRAQARRLADFLRAGPAAPDADLAYSLATTRATLTDRAVVVAADRAEAIARLTALAEGDQGPRVARATAVPRDRLAFVFPGQGSQWPGMAAELMSCYPVFRESIKECGRSLAPHTDWSLAKVLRGESGAPTLDRVDVVQPALFAVMVSLAALWRSFGVEPSAVAGHSQGEIAAARVAGALSLEDAARVVALRSRALRVLSGRGGMVSVAAPAGQVLRTLERWGGAVSVAAVNGPRSLVISGDPGALGEALAAFEAEGIRARRIPVDYASHSAQVEEIRDTLLTELSGIRPRPATVPFYSTVSGEPLDTTALDTGYWVRNLRDTVQFDRTVRRLLADGHTTFLEMSPHPVLTPGIQETAEEAGADEVLTVESLRRNEGGPARLLTAVAEAHVHGVAVDWSPAFAPHRSPARRPAVLRLSSGAATGLRTRPRPPPMFTTAGLDGIDHPLLGAAIPLADGGGGTLFTGTLSLATHPWLADHAVADVLVVPGTALVEAALRAGAECTGRAMLEELVLQAPLILPEQGTVRIQLSVGGPDGTGRRALILSSRPEDAGADEPWTRHAEGTLAPGGGHPRQDPGPWPPTGAREIDLDDCYRQLAKTGLHYGPAFQGLKRLWRLADDLCLEAELPDSAGESGRYGLHPALFDAALHAAALAGPSGAEPLTRLPFSWSGVALYTAGATRLRARLSFTGPQSLTLTAMDPLGHPVLSVGTLGMRPVTAEALHRAAGTAGTALLRLEWRRQAPEHPAGPDLTGWAWVGAGAPPAQPPDGRPYRDLAALRAELDAGAAVPPVIVLAEPATPEGTDPFTAARAALHRTLAAIQDWAAEERLAGTRLVVLTQGAVAATPGALPDPALAAVWGLVRSAQAEYPDRIGLVDTDDPGRSRAAVAAAVHAGEAQAAVRDGALLVPRLARVTATDGPGGPAWPADGTVLVTGGLGTLGRLVVRHLVTTHGARRLVILSRSGGDSAEVREFVGELLAQGANVQVVKGDAADPAVLERVLDGIPQEHPLAAVAHLAGALDDGVLAAQTPQRLDRVLRPKAEAAWQLHRLTARARVPLLAFSSLSGVLGPAGQAGYAAANAFVDALVQRRRGTGLPGVSMGWGMWATRSGLTGALSDTDARLIARTGVRPLTDEEGLALFDQARATGEPVVFPLGLDITALNSGAPDGIPPLLRGLTARTPARRAGAAEAPEPAGEDLAARLAATPEAERDALLLGVVRGHIAAVLGYDDPRAVAERRPFSDIGFDSLRALQLRNRLGAATGRRLPATLVFDHPNPAALSRYLRTLLLPDPAPAPTAPDGQPGPDQADQVIERLNSASLEEVLDFIDHQLGE

[Multiple Choices]
A. regulation of establishment of protein localization
B. antibiotic biosynthetic process
C. regulation of biosynthetic process
D. protein import into nucleus
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The matched sequence is annotated as a component of a type I modular polyketide synthase that generates the antibiotic spectinabilin backbone. The annotation cites experimental evidence, supporting antibiotic biosynthesis (choice B).

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C6](#evidence-c6), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a catalytic biosynthetic megasynthase, which argues against protein-localization and regulatory choices. But identifying its product specifically as an antibiotic is not established by that general inference.


**Missing item-specific fact**

> The protein’s identity as NorA in the spectinabilin antibiotic biosynthesis pathway.


**Reason**

> The supplied sequence can support a broad biosynthetic role, but distinguishing antibiotic biosynthesis from other biosynthetic functions requires the protein-specific pathway or product assignment, absent from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The evidence supports choice B; the alternatives describe regulation or protein transport/localization rather than the annotated biosynthetic role.


### Important caveats

- The sequence matches the cited UniProt entry, including the historical entry version, but the author’s exact source snapshot is unknown.
- The function annotation cites experimental evidence, though the cited primary study was not independently retrieved or assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a catalytic biosynthetic megasynthase, which argues against protein-localization and regulatory choices. But identifying its product specifically as an antibiotic is not established by that general inference.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s identity as NorA in the spectinabilin antibiotic biosynthesis pathway.",
    "reason": "The supplied sequence can support a broad biosynthetic role, but distinguishing antibiotic biosynthesis from other biosynthetic functions requires the protein-specific pathway or product assignment, absent from the input."
  },
  "case_id": "GO_biological_process_0066",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C6",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The matched sequence is annotated as a component of a type I modular polyketide synthase that generates the antibiotic spectinabilin backbone. The annotation cites experimental evidence, supporting antibiotic biosynthesis (choice B)."
  },
  "important_caveats": [
    "The sequence matches the cited UniProt entry, including the historical entry version, but the author’s exact source snapshot is unknown.",
    "The function annotation cites experimental evidence, though the cited primary study was not independently retrieved or assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports choice B; the alternatives describe regulation or protein transport/localization rather than the annotated biosynthetic role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0066",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched sequence is annotated as a component of a type I modular polyketide synthase that generates the antibiotic spectinabilin backbone. The annotation cites experimental evidence, supporting antibiotic biosynthesis (choice B).",
    "evidence_ids": ["C5", "H3", "C6", "H4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a catalytic biosynthetic megasynthase, which argues against protein-localization and regulatory choices. But identifying its product specifically as an antibiotic is not established by that general inference.",
    "missing_item_specific_fact": "The protein’s identity as NorA in the spectinabilin antibiotic biosynthesis pathway.",
    "reason": "The supplied sequence can support a broad biosynthetic role, but distinguishing antibiotic biosynthesis from other biosynthetic functions requires the protein-specific pathway or product assignment, absent from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The evidence supports choice B; the alternatives describe regulation or protein transport/localization rather than the annotated biosynthetic role."
  },
  "important_caveats": [
    "The sequence matches the cited UniProt entry, including the historical entry version, but the author’s exact source snapshot is unknown.",
    "The function annotation cites experimental evidence, though the cited primary study was not independently retrieved or assessed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry B4ER92 (sequence matched, 1897 aa) is annotated as 'Spectinabilin polyketide synthase system protein NorA' (EC 2.3.1.290). The FUNCTION comment (ECO:0000269, PubMed:17763486) states it is a component of a type I modular PKS generating the backbone of the antibiotic spectinabilin. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' (ECO:0000305). The GO annotation GO:0033068 (macrolide biosynthetic process) is_a GO:0017000 (antibiotic biosynthetic process), confirming the hierarchy. The evidence is experimental (PubMed:17763486) and directly applies to the supplied sequence.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C7](#evidence-c7), [H3](#evidence-h3), [H4](#evidence-h4), [H5](#evidence-h5), [GO4](#evidence-go4), [GO3](#evidence-go3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1897-aa sequence contains recognizable type I modular PKS domain architecture: acyltransferase GxSxG-like motifs (e.g., 'GATVMATPWGY'), ketosynthase cysteine-containing regions, acyl carrier protein-like segments, and a C-terminal thioesterase domain. This multi-catalytic-domain architecture identifies the protein as a biosynthetic enzyme directly catalyzing carbon-chain assembly, not a regulatory factor. This eliminates C (regulation of biosynthetic process) because a PKS is the biosynthetic machinery itself, not a modulator of other biosynthetic pathways. It eliminates A (regulation of establishment of protein localization) and D (protein import into nucleus) because these are eukaryotic trafficking/localization processes incompatible with a bacterial multi-domain catalytic enzyme. Among the four options, only B (antibiotic biosynthetic process) is consistent with a direct biosynthetic enzyme in a Streptomyces organism.


**Missing item-specific fact**

> The specific identification of spectinabilin as an 'antibiotic' (rather than a generic polyketide or fatty acid) requires knowing that this particular PKS product has antimicrobial activity. However, this is largely inferable from the Streptomyces genus (overwhelmingly antibiotic-producing) and the unusual 4-nitrobenzoyl-CoA starter unit characteristic of specialized/antibiotic PKS rather than primary metabolic PKS.


**Reason**

> The elimination logic from sequence-derived domain architecture (PKS = biosynthetic enzyme, not a regulator; bacterial = not nuclear import; catalytic multi-domain = not a localization factor) provides a concrete biological argument that meaningfully distinguishes B from A, C, and D without requiring memorization of the exact UniProt annotation. The specific 'antibiotic' qualifier is supported by general knowledge of Streptomyces secondary metabolism and the unusual starter unit.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, C, and D are clearly incompatible with a multi-domain catalytic biosynthetic enzyme in a bacterium. C ('regulation of biosynthetic process') might superficially seem adjacent, but a PKS is the biosynthetic machinery, not a regulator. No other option is defensible for a type I modular PKS.


### Important caveats

- The GO annotations on UniProt for this protein are IEA (Inferred from Electronic Annotation) for fatty acid and macrolide biosynthetic processes; the direct 'Antibiotic biosynthesis' pathway comment is ECO:0000305 (inferred from reference), not a direct GO annotation.
- The sequence is 1897 aa; recognizing individual PKS domain motifs from raw sequence without a domain annotation tool requires substantial expertise, though the overall multi-domain architecture and length are suggestive.
- The identity of the protein (B4ER92) was inferred by the reviewer from dataset metadata; the evaluated model only sees the sequence and choices.
- The exact historical ontology snapshot used by the benchmark author is unknown, though GO:0017000 has been stable for many years.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1897-aa sequence contains recognizable type I modular PKS domain architecture: acyltransferase GxSxG-like motifs (e.g., 'GATVMATPWGY'), ketosynthase cysteine-containing regions, acyl carrier protein-like segments, and a C-terminal thioesterase domain. This multi-catalytic-domain architecture identifies the protein as a biosynthetic enzyme directly catalyzing carbon-chain assembly, not a regulatory factor. This eliminates C (regulation of biosynthetic process) because a PKS is the biosynthetic machinery itself, not a modulator of other biosynthetic pathways. It eliminates A (regulation of establishment of protein localization) and D (protein import into nucleus) because these are eukaryotic trafficking/localization processes incompatible with a bacterial multi-domain catalytic enzyme. Among the four options, only B (antibiotic biosynthetic process) is consistent with a direct biosynthetic enzyme in a Streptomyces organism.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The specific identification of spectinabilin as an 'antibiotic' (rather than a generic polyketide or fatty acid) requires knowing that this particular PKS product has antimicrobial activity. However, this is largely inferable from the Streptomyces genus (overwhelmingly antibiotic-producing) and the unusual 4-nitrobenzoyl-CoA starter unit characteristic of specialized/antibiotic PKS rather than primary metabolic PKS.",
    "reason": "The elimination logic from sequence-derived domain architecture (PKS = biosynthetic enzyme, not a regulator; bacterial = not nuclear import; catalytic multi-domain = not a localization factor) provides a concrete biological argument that meaningfully distinguishes B from A, C, and D without requiring memorization of the exact UniProt annotation. The specific 'antibiotic' qualifier is supported by general knowledge of Streptomyces secondary metabolism and the unusual starter unit."
  },
  "case_id": "GO_biological_process_0066",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C7",
      "H3",
      "H4",
      "H5",
      "GO4",
      "GO3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry B4ER92 (sequence matched, 1897 aa) is annotated as 'Spectinabilin polyketide synthase system protein NorA' (EC 2.3.1.290). The FUNCTION comment (ECO:0000269, PubMed:17763486) states it is a component of a type I modular PKS generating the backbone of the antibiotic spectinabilin. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' (ECO:0000305). The GO annotation GO:0033068 (macrolide biosynthetic process) is_a GO:0017000 (antibiotic biosynthetic process), confirming the hierarchy. The evidence is experimental (PubMed:17763486) and directly applies to the supplied sequence."
  },
  "important_caveats": [
    "The GO annotations on UniProt for this protein are IEA (Inferred from Electronic Annotation) for fatty acid and macrolide biosynthetic processes; the direct 'Antibiotic biosynthesis' pathway comment is ECO:0000305 (inferred from reference), not a direct GO annotation.",
    "The sequence is 1897 aa; recognizing individual PKS domain motifs from raw sequence without a domain annotation tool requires substantial expertise, though the overall multi-domain architecture and length are suggestive.",
    "The identity of the protein (B4ER92) was inferred by the reviewer from dataset metadata; the evaluated model only sees the sequence and choices.",
    "The exact historical ontology snapshot used by the benchmark author is unknown, though GO:0017000 has been stable for many years."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are clearly incompatible with a multi-domain catalytic biosynthetic enzyme in a bacterium. C ('regulation of biosynthetic process') might superficially seem adjacent, but a PKS is the biosynthetic machinery, not a regulator. No other option is defensible for a type I modular PKS."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0066",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry B4ER92 (sequence matched, 1897 aa) is annotated as 'Spectinabilin polyketide synthase system protein NorA' (EC 2.3.1.290). The FUNCTION comment (ECO:0000269, PubMed:17763486) states it is a component of a type I modular PKS generating the backbone of the antibiotic spectinabilin. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' (ECO:0000305). The GO annotation GO:0033068 (macrolide biosynthetic process) is_a GO:0017000 (antibiotic biosynthetic process), confirming the hierarchy. The evidence is experimental (PubMed:17763486) and directly applies to the supplied sequence.",
    "evidence_ids": ["C4", "C5", "C6", "C7", "H3", "H4", "H5", "GO4", "GO3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1897-aa sequence contains recognizable type I modular PKS domain architecture: acyltransferase GxSxG-like motifs (e.g., 'GATVMATPWGY'), ketosynthase cysteine-containing regions, acyl carrier protein-like segments, and a C-terminal thioesterase domain. This multi-catalytic-domain architecture identifies the protein as a biosynthetic enzyme directly catalyzing carbon-chain assembly, not a regulatory factor. This eliminates C (regulation of biosynthetic process) because a PKS is the biosynthetic machinery itself, not a modulator of other biosynthetic pathways. It eliminates A (regulation of establishment of protein localization) and D (protein import into nucleus) because these are eukaryotic trafficking/localization processes incompatible with a bacterial multi-domain catalytic enzyme. Among the four options, only B (antibiotic biosynthetic process) is consistent with a direct biosynthetic enzyme in a Streptomyces organism.",
    "missing_item_specific_fact": "The specific identification of spectinabilin as an 'antibiotic' (rather than a generic polyketide or fatty acid) requires knowing that this particular PKS product has antimicrobial activity. However, this is largely inferable from the Streptomyces genus (overwhelmingly antibiotic-producing) and the unusual 4-nitrobenzoyl-CoA starter unit characteristic of specialized/antibiotic PKS rather than primary metabolic PKS.",
    "reason": "The elimination logic from sequence-derived domain architecture (PKS = biosynthetic enzyme, not a regulator; bacterial = not nuclear import; catalytic multi-domain = not a localization factor) provides a concrete biological argument that meaningfully distinguishes B from A, C, and D without requiring memorization of the exact UniProt annotation. The specific 'antibiotic' qualifier is supported by general knowledge of Streptomyces secondary metabolism and the unusual starter unit."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are clearly incompatible with a multi-domain catalytic biosynthetic enzyme in a bacterium. C ('regulation of biosynthetic process') might superficially seem adjacent, but a PKS is the biosynthetic machinery, not a regulator. No other option is defensible for a type I modular PKS."
  },
  "important_caveats": [
    "The GO annotations on UniProt for this protein are IEA (Inferred from Electronic Annotation) for fatty acid and macrolide biosynthetic processes; the direct 'Antibiotic biosynthesis' pathway comment is ECO:0000305 (inferred from reference), not a direct GO annotation.",
    "The sequence is 1897 aa; recognizing individual PKS domain motifs from raw sequence without a domain annotation tool requires substantial expertise, though the overall multi-domain architecture and length are suggestive.",
    "The identity of the protein (B4ER92) was inferred by the reviewer from dataset metadata; the evaluated model only sees the sequence and choices.",
    "The exact historical ontology snapshot used by the benchmark author is unknown, though GO:0017000 has been stable for many years."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `B4ER92` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 83. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:00.659517+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000312","id":"CAO85893.1","source":"EMBL"}],"value":"Modular polyketide synthase NorA"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"17763486","source":"PubMed"}],"value":"2.3.1.290"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Spectinabilin polyketide synthase system protein NorA"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Spectinabilin PKS system protein NorA"}]}}
```

Source SHA-256: `5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:00.659517+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"17763486","source":"PubMed"}],"value":"Component of a type I modular polyketide synthase (PKS) that generates the backbone of the antibiotic spectinabilin (also known as neoaureothin), a nitroaryl-substituted polyketide metabolite (PubMed:17763486). This PKS system accepts the unusual starter unit 4-nitrobenzoyl-CoA and extends it by 6 molecules of (S)-methylmalonyl-CoA and a single molecule of malonyl-CoA (PubMed:17763486). The first module, NorA, is used twice in an iterative fashion (PubMed:17763486)"}]}
```

Source SHA-256: `5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:00.659517+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"17763486","source":"PubMed"}],"value":"Antibiotic biosynthesis"}]}
```

Source SHA-256: `5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)  
**Locator:** `/comments/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:00.659517+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"17763486","source":"PubMed"}],"value":"Polyketide biosynthesis"}]}
```

Source SHA-256: `5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)  
**Locator:** `lines 23-30`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 83 / 1.  
**Retrieved:** 2026-11-01T06:27:51.676658+00:00.  

```text
CC   -!- FUNCTION: Component of a type I modular polyketide synthase (PKS) that
CC       generates the backbone of the antibiotic spectinabilin (also known as
CC       neoaureothin), a nitroaryl-substituted polyketide metabolite
CC       (PubMed:17763486). This PKS system accepts the unusual starter unit 4-
CC       nitrobenzoyl-CoA and extends it by 6 molecules of (S)-methylmalonyl-CoA
CC       and a single molecule of malonyl-CoA (PubMed:17763486). The first
CC       module, NorA, is used twice in an iterative fashion (PubMed:17763486).
CC       {ECO:0000269|PubMed:17763486}.
```

Source SHA-256: `3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)  
**Locator:** `lines 44-44`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 83 / 1.  
**Retrieved:** 2026-11-01T06:27:51.676658+00:00.  

```text
CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000305|PubMed:17763486}.
```

Source SHA-256: `3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)  
**Locator:** `lines 45-45`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 83 / 1.  
**Retrieved:** 2026-11-01T06:27:51.676658+00:00.  

```text
CC   -!- PATHWAY: Polyketide biosynthesis. {ECO:0000305|PubMed:17763486}.
```

Source SHA-256: `3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a`.

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 132339-132351`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0017000
name: antibiotic biosynthetic process
namespace: biological_process
def: "The chemical reactions and pathways resulting in the formation of an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms." [GOC:curators]
subset: goslim_metagenomics
synonym: "antibiotic anabolism" EXACT []
synonym: "antibiotic biosynthesis" EXACT []
synonym: "antibiotic formation" EXACT []
synonym: "antibiotic synthesis" EXACT []
is_a: GO:0009058 ! biosynthetic process
is_a: GO:0016999 ! antibiotic metabolic process

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 193399-193412`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0033068
name: macrolide biosynthetic process
namespace: biological_process
def: "The chemical reactions and pathways leading to the formation of macrolides, any of a large group of polyketide compounds that contain a large lactone ring with few or no double bonds and no nitrogen atoms, linked glycosidically to one or more sugar groups. The macrolides include the carbomycins, the erythromycins, oleandomycin, oligomycins, and the spiramycins, and act as antibiotics, mainly against Gram-positive bacteria." [ISBN:0198506732, PMID:17298179]
synonym: "macrolide anabolism" EXACT []
synonym: "macrolide biosynthesis" EXACT []
synonym: "macrolide formation" EXACT []
synonym: "macrolide synthesis" EXACT []
is_a: GO:0017000 ! antibiotic biosynthetic process
is_a: GO:0030639 ! polyketide biosynthetic process
is_a: GO:0033067 ! macrolide metabolic process
is_a: GO:1901336 ! lactone biosynthetic process

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 66. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
